Celebrate Rare Cancer Day with NORD

View NORD’s Rare Cancer Day 2025 Webinar
Biomarker testing is transforming how rare cancers are diagnosed and treated, opening the door to more precise and personalized care. Yet, for many patients and families, the path to accessing testing can be confusing or difficult.
In honor of Rare Cancer Day, experts and patient advocates broke down what biomarker testing is, why it matters, and how to overcome barriers to access. Hear real patient stories and gain practical insights to better understand and advocate for biomarker testing.
Brought to you by NORD’s Rare Cancer Coalition, this webinar is suitable for patients, caregivers, advocates, health professionals and the public.

Jim Palma, CEO, Target Cancer Foundation; NORD Board Member

Dr. Haley Ellis, Oncologist and Clinician Scientist, Massachusetts General Hospital and Harvard Medical School

Alexandria Caron, Membership Manager, NORD

Sanjeev Kumar, Founder & CEO, Gallbladder Cancer Foundation
Get Involved on Social
Join the conversation this Rare Cancer Day and raise awareness by sharing information about rare cancer on social media. Your voice matters in spreading knowledge and fostering support for those affected by rare cancer. #RareCancerDay
- Download Rare Cancer Day Social Media Toolkit
- Download Rare Cancer Day Infographic
- Download Rare Cancer Day Social Media Posts Assets
What to Know About Rare Cancer
Click and download the individual graphics below for sharing or click here to download the all the images at once. All of the Rare Cancer Day graphics are free for public use.
Continuing Medical Education
NORD and Platform Q health are proud to feature ongoing courses about Rare Cancers as an important part of our CME offerings. These courses are available for credit for one year following their publication.
Click here to check out some of the past and present CME sessions on Rare Cancer.










